Aditya Gupta is an LL.M. student at Harvard Law School interested in issues involving the intersection of health care and intellectual property law and policy and the need for health care and patent law reform in both developed and developing countries. Aditya has practiced as a litigator at an intellectual property law firm in India for three years. During that time, he was part of some of India’s high profile pharmaceutical patent litigation including the Novartis case decided by the Indian Supreme Court.
A few of Aditya’s recent publications include:
- Anand and Gupta, Do India’s compulsory licenses violate TRIPs, Managing IP, December 2012 – January, 2013, Buxton Press, Buxton, United Kingdom
- Anand and Gupta, Compulsory Licensing: What the Controller got wrong, Managing IP (India IP Focus), 2012, Buxton Press, Buxton, United Kingdom